🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
The primary objective of the study was to evaluate the efficacy of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01807949
Treatments Being Tested
This Phase 3 study is conducted to evaluate lanifibranor in adults with NAS...
Status
Active Not Recruiting
Location
Objective Health - Birmingham Gastroenterology Associates
Start Date
2021-08-19
Trial ID
NCT04849728
This is a Phase 2, randomized, double blind, placebo and active-controlled,...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02951195
The purpose of this study is to demonstrate the superior efficacy of Xevina...
Status
Terminated
Location
University of Alabama at Birmingham - Dept of Radiation Oncology
Start Date
2022-10-06
Trial ID
NCT05386550
Treatments Being Tested
To evaluate the efficacy and safety of lumacaftor in combination with ivaca...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02514473
This is a phase III, randomized, double-blind, placebo-controlled, multicen...
Status
Completed
Location
InSys Therapeutics, Incorporated
Start Date
2007-10
Trial ID
NCT00538850
Treatments Being Tested
This study will explore the impact of lumacaftor/ivacaftor (LUM/IVA) on dis...
Status
Completed
Location
Charite Paediatric Pulmonology Department
Start Date
2018-08-10
Trial ID
NCT03625466